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Background
Cow’s milk proteins allergy (CMPA) is the most common
food allergy in childhood, affecting up to 2.5% of infants.
The immune mechanisms underlying non-IgE-mediated
clinical presentations, which mostly affect the gastrointest-
inal system and are sometimes very severe, are not fully
understood. Currently, specific oral tolerance induction
(SOTI) is available as a specific treatment for CMPA, but
most studies of this approach have focused on IgE-
mediated forms of this food allergy.
Methods
Children, with non-IgE-mediated CMPA, underwent
SOTI using a protocol consisting of oral ingestion of
increasing doses of cow’s milk, always in Hospital settings,
until reaching a 200 mL dose per day, before introduction
of an unrestricted diet.
Results
Five children aged from 19 months to 4 years (3 males,
2 females) with a history of CMPA, since the first year
of life and predominantly manifested by gastrointestinal
symptoms, were included. All patients have completed
the protocol and remain on an unrestricted diet. During
SOTI three children had mild to moderate reactions,
mainly abdominal pain and with spontaneous resolution,
but sometimes justifying protocol adjustment.
Conclusion
Despite clinical and immunological differences between
IgE and non IgE CMPA, this protocol appears also to be a
safe and effective alternative in the management of non-
IgE-mediated CMPA, reducing the risk of accidental reac-
tions and improving quality of life of chidren and their
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